Literature DB >> 28933966

Mobile Laser Indirect Ophthalmoscope: For the Induction of Choroidal Neovascularization in a Mouse Model.

Dov Weinberger1,2,3, Elite Bor-Shavit2, Tilda Barliya1, Mor Dahbash1, Opher Kinrot4, Dan D Gaton2,3, Yael Nisgav1, Tami Livnat1,3,5.   

Abstract

PURPOSE: This study aims to evaluate and standardize the reliability of a mobile laser indirect ophthalmoscope in the induction of choroidal neovascularization (CNV) in a mouse model. MATERIALS &
METHODS: A diode laser indirect ophthalmoscope was used to induce CNV in pigmented male C57BL/6J mice. Standardization of spot size and laser intensity was determined using different aspheric lenses with increasing laser intensities applied around the optic disc. Development of CNV was evaluated 1, 5, and 14 days post laser application using fluorescein angiography (FA), histology, and choroidal flat mounts stained for the endothelial marker CD31 and FITC-dextran. Correlation between the number of laser hits to the number and size of developed CNV lesions was determined using flat mount choroid staining. The ability of intravitreally injected anti-human and anti-mouse VEGF antibodies to inhibit CNV induced by the mobile laser was evaluated.
RESULTS: Laser parameters were standardized on 350 mW for 100 msec, using the 90 diopter lens to accomplish the highest incidence of Bruch's membrane rupture. CNV lesions' formation was validated on days 5 and 14 post laser injury, though FA showed leakage on as early as day 1. The number of laser hits was significantly correlated with the CNV area. CNV growth was successfully inhibited by both anti-human and mouse VEGF antibodies.
CONCLUSION: The mobile laser indirect ophthalmoscope can serve as a feasible and a reliable alternative method for the CNV induction in a mouse model.

Entities:  

Keywords:  Anti VEGF; CNV; mobile laser; mouse model; ophthalmoscope

Mesh:

Substances:

Year:  2017        PMID: 28933966     DOI: 10.1080/02713683.2017.1349154

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  5 in total

1.  Celastrol inhibits laser-induced choroidal neovascularization by decreasing VEGF induced proliferation and migration.

Authors:  Zhen Li; Ke-Wen Zhou; Fang Chen; Fu Shang; Ming-Xing Wu
Journal:  Int J Ophthalmol       Date:  2022-08-18       Impact factor: 1.645

2.  The Histone Deacetylase Inhibitor AN7, Attenuates Choroidal Neovascularization in a Mouse Model.

Authors:  Mor Dahbash; Ruti Sella; Elinor Megiddo-Barnir; Yael Nisgav; Nataly Tarasenko; Dov Weinberger; Ada Rephaeli; Tami Livnat
Journal:  Int J Mol Sci       Date:  2019-02-07       Impact factor: 5.923

3.  Activated Protein C (APC) and 3K3A-APC-Induced Regression of Choroidal Neovascularization (CNV) Is Accompanied by Vascular Endothelial Growth Factor (VEGF) Reduction.

Authors:  Tami Livnat; Yehonatan Weinberger; José A Fernández; Alaa Bashir; Gil Ben-David; Dahlia Palevski; Sarina Levy-Mendelovich; Gili Kenet; Ivan Budnik; Yael Nisgav; John H Griffin; Dov Weinberger
Journal:  Biomolecules       Date:  2021-02-26

4.  Alpinumisoflavone ameliorates choroidal neovascularisation and fibrosis in age-related macular degeneration in in vitro and in vivo models.

Authors:  Eunhye Yu; Yunjeong Song; Sun Mi Gu; Yang Hee Jo; Sang Won Yeon; Kyu Jin Han; Mi Kyeong Lee; Jung Kee Min; Jaesuk Yun
Journal:  Sci Rep       Date:  2022-08-22       Impact factor: 4.996

5.  CRISPR-LbCpf1 prevents choroidal neovascularization in a mouse model of age-related macular degeneration.

Authors:  Taeyoung Koo; Sung Wook Park; Dong Hyun Jo; Daesik Kim; Jin Hyoung Kim; Hee-Yeon Cho; Jeungeun Kim; Jeong Hun Kim; Jin-Soo Kim
Journal:  Nat Commun       Date:  2018-05-10       Impact factor: 14.919

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.